Primary Hepatic Neuroendocrine Tumor after 4 years Tumor-free Follow-up

Authors

  • Ioana Maria Lambrescu Carol Davila University of Medicine and Pharmacy, PhD student, Bucharest, Romania
  • Sorina Martin Endocrinology Department Elias University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • Luminita Cima Carol Davila University of Medicine and Pharmacy, PhD student, Bucharest, Romania
  • Vlad Herlea Pathology Department, Fundeni Clinical Institute, Bucharest, Romania
  • Corin Badiu National Institute of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
  • Simona Fica Endocrinology Department Elias University Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

DOI:

https://doi.org/10.15403/jgld.2014.1121.242.4yrs

Keywords:

neuroendocrine tumor, primary hepatic neuroendocrine tumor, chromogranin A

Abstract

Background: A primary hepatic neuroendocrine tumour (PHNET) is a very rare disease. The liver represents the preferential site for neuroendocrine tumors' metastases.

Case presentation: A 45-year old Caucasian female who presented with nausea, vomiting, diarrhea, accompanied by diffuse abdominal pain was found to have on contrast-enhanced computer tomography an encapsulated, partially cystic liver mass. The patient underwent an uneventful left atypical hepatic resection. Histopatological and immunohistochemical examination revealed a slowly growing (G1) hepatic neuroendocrine tumour. Post surgery, the specific neuroendocrine markers (serum Chromogranin A and 24h urinary 5 hydroxy-indolacetic acid) were within normal range. Further functional imaging investigations were performed. No other lesions were found making probable the diagnosis of PHNET. The patient is presently after 4 years of follow-up with no local recurrence or distant metastases.

Conclusions:
 The diagnosis of PHNET is a medical challenge that requires a thorough longterm follow-up in order to exclude an occult primary neuroendocrine tumour.

Downloads

Published

2015-06-01

How to Cite

1.
Lambrescu IM, Martin S, Cima L, Herlea V, Badiu C, Fica S. Primary Hepatic Neuroendocrine Tumor after 4 years Tumor-free Follow-up. JGLD [Internet]. 2015 Jun. 1 [cited 2025 Jun. 15];24(2):241-4. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/1225

Issue

Section

Case Reports